Cell-based
Assay Market, By Product (Cell Lines, Microplates, Instruments, Software,
Reagents and Assay Kits and Others), By Application (Drug Discovery, Predictive
Toxicology, ADME Process and Others), By End-User (Pharmaceutical Companies,
Biotechnology Companies, Research Organizations, Government & Academic Institutes
and Others) and Geography– Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2026
Cell-based assay refers to
experiments based on living cells and is an influential tool in the research
lab. Cell-based assays are vital for understanding cellular mechanism in a
biological context as these assays provide information about intracellular
molecular targets. There are variety of assays used to measure motility,
toxicity, cell proliferation, production of a measurable product, and
morphology. Cell-based assays provides accuracy in obtaining the data of
various parameters of the real-life model as live cells are used, cell-based
assays are now used in drug discovery and checking the toxicity of new or old
drugs used by population. With the rapid growth of pharmaceutical and biotechnological
sector worldwide and emerging development of new drugs, the demand for
cell-based assay is expected to witness a rapid increase. Companies are
adopting the cell-based assay order to reverse the costly late-stage drug
failure and thus the rising surge of cell-based assay is expect to have a
positive effect on market growth in near future.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1273
Cumulative growth in drug
discovery is expected to boost cell-based assay market in forecast period
Rapid growth in drug discovery is
expected to increase the demand for cell-based assay as it is mainly used in
checking toxicity of drugs. For instance according to FDA’s Center for Drug
Evaluation and Research (CDER) in 2016, CDER approves averagely 30 novel drugs
per year and the development of novel drug discovery is expected to increase in
future. Many companies are involved in the drug discovery needs cell-based
assay for testing new drugs that is expected to boost the cell-based assay
market in forecast period. Since pharmaceutical market have become a billion-dollar
business, many pharmaceutical and biotechnological companies are adopting
cell-based assay in order to reduce the chances of failure of batch which lead
to a high loss to company. Thus, the adoption of this method by companies is
expected to fuel its market in near future. However, high maintenance, need for
skilled personnel and high-cost of operation for the cell based assays are
expected to hinder the market growth.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/cell-based-assay-market-1273
North America is expected to
dominate cell-based assay market due to growing pharmaceutical sector in region
Regional segmentation of
cell-based assay market by Coherent Market Insights includes North America,
Latin America, Europe, Asia Pacific, Middle East and Africa. North America is
expected to hold a dominant position in the cell-based assay market due to
rapid growth of pharmaceutical and biotechnology manufacturing sector.
According to a study published in International Trade Administration in 2016,
U.S. is a major hub for drug manufacturing and the market is expected to grow
drastically in future which is expected to fuel cell-based assay market in
North America. Asia pacific is expected to follow North America market in
upcoming period of time due to increase in pharmaceutical and biotechnological
sector in China and India which will increase the demand for cell-based assay
and fuel its market in forecast period.
DiscoverX Corporation launched
in-cell pulse cell-based assays for confirmation of compound-target engagement
in drug discovery
Major key players in cell-based
assay market are DiscoverX Corporation, Becton, Dickinson and Company, cell
Signaling Technology, Inc., Becton, Danaher Corporation, Thermo Fisher
Scientific, Inc., Cisbio Bioassays, Merck & Co., and PerkinElmer, Inc. and
others. DiscoverX Corporation, one of the leading supplier of cell-based assay
in 2016 introduced InCELL Pulse target engagement platform that provides
scientists with the ability to generate their own cell-based target engagement
assays for confirming compound cell entry and target binding in the native
cellular environment.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1273
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment